Macquarie Group Reduces Bitcoin and Ethereum ETF Holdings, Increases Positions in Circle and BitMine Stocks

iconKuCoinFlash
Share
AI summary iconSummary
Macquarie Group reduced its holdings in Bitcoin and Ethereum ETFs in its Q1 2026 filings as ETF inflows slowed. The firm’s stake in IBIT declined by 19.3% to 4.139 million shares, valued at $159 million, down from $255 million. Its ETHA holdings fell 9.5% to 3.289 million shares, worth $52.1 million, from $81.5 million. Meanwhile, Macquarie increased its position in Circle by 188% to $2.326 million and added a $4.153 million stake in BitMine. These moves may reflect shifting sentiment amid a bearish Fear & Greed Index.

Odaily Planet Daily reports that according to Macquarie Group Ltd’s 13F filing submitted in mid-May, comparing the 13F reports as of December 31, 2025, and March 31, 2026, its holdings of IBIT decreased from 5.126 million shares to 4.139 million shares, a reduction of approximately 19.3%, with the corresponding asset value declining from approximately $255 million to $159 million. Its holdings of ETHA fell from 3.634 million shares to 3.289 million shares, a decrease of about 9.5%, with the corresponding asset value dropping from approximately $815 million to $521 million.

In cryptocurrency stocks, Macquarie Group reduced its position in Coinbase by 19%, increased its position in Circle by 188%, reaching a value of $2.326 million as of the end of the first quarter, and added a position in BitMine, valued at $4.153 million as of the end of the first quarter.

Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information. Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.